{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:01:36Z","timestamp":1769598096293,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,7]],"date-time":"2015-07-07T00:00:00Z","timestamp":1436227200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12894-015-0046-1","type":"journal-article","created":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T10:47:40Z","timestamp":1436179660000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Sodium hyaluronate and chondroitin sulfate replenishment therapy can improve nocturia in men with post-radiation cystitis: results of a prospective pilot study"],"prefix":"10.1186","volume":"15","author":[{"given":"Mauro","family":"Gacci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Giannessi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Detti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Livi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Monteleone Pasquetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Masoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Finazzi Agro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Li Marzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Minervini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Carini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stavros","family":"Gravas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Oelke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Serni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,7]]},"reference":[{"key":"46_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ijrobp.2007.06.054","volume":"70","author":"DA Kuban","year":"2008","unstructured":"Kuban DA, Tucker SL, Dong L, et al. Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys. 2008;70:67\u201374.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"46_CR2","unstructured":"EAU guidelines http:\/\/www.uroweb.org\/guidelines\/online-guidelines\/ . Accessed 25 June 2014."},{"key":"46_CR3","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(05)67101-2","volume":"366","author":"M Bolla","year":"2005","unstructured":"Bolla M, Van Poppel H, Collette L, et al. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial, 22911). Lancet. 2005;366:572\u20138.","journal-title":"Lancet"},{"issue":"2","key":"46_CR4","doi-asserted-by":"publisher","first-page":"393e399","DOI":"10.1016\/j.ijrobp.2012.02.061","volume":"85","author":"S Langhe De","year":"2013","unstructured":"De Langhe S et al. Acute radiation-induced nocturia in prostate cancer patients is associated with pretreatment symptoms, radical prostatectomy, and genetic markers in the TGFb1 gene. Int J Radiat Oncol Biol Phys. 2013;85(2):393e399.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"46_CR5","first-page":"777","volume":"60","author":"L GDe Meerleer","year":"2004","unstructured":"GDe Meerleer L, Vakaet S. Meersschout et al. Intensity-modulated radiotherapy as primary treatment for prostate cancer: acute toxicity in 114 patients. Phys. 2004;60:777\u201387.","journal-title":"Phys"},{"key":"46_CR6","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00345-014-1396-0","volume":"32","author":"O Matthias","year":"2014","unstructured":"Matthias O et al. Nocturia: state of the art and critical analysis of current assessment and treatment strategies. World J Urol. 2014;32:1109\u201317.","journal-title":"World J Urol"},{"key":"46_CR7","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1002\/nau.22585","volume":"33","author":"DL Bliwise","year":"2014","unstructured":"Bliwise DL, Rosen RC, Baum N. Impact of nocturia on sleep and quality of life: a brief, selected review for the international consultation on incontinence research society (ICI-RS) nocturia think tank. Neurourol Urodyn. 2014;33:S15\u20138.","journal-title":"Neurourol Urodyn"},{"key":"46_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1177\/1756287213490052","volume":"5","author":"C Giberti","year":"2013","unstructured":"Giberti C, Gallo F, Cortese P, Schenone M. Combined intravesical sodium hyaluronate\/chondroitin sulfate therapy for interstitial cystitis\/bladder pain syndrome: a prospective study. Ther Adv Urol. 2013;5:175\u20139.","journal-title":"Ther Adv Urol"},{"key":"46_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1177\/1756287211418723","volume":"3","author":"R Damiano","year":"2011","unstructured":"Damiano R, Cicione A. The role of sodium hyaluronate and sodium chondroitin sulphate in the management of bladder disease. Ther Adv Urol. 2011;3:223\u201332.","journal-title":"Ther Adv Urol"},{"key":"46_CR10","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s00192-011-1546-5","volume":"23","author":"P Daniele","year":"2012","unstructured":"Daniele P et al. Impact of intravesical hyaluronic acid and chondroitin sulfate on bladder pain syndrome\/interstitial cystitis. Int Urogynecol J. 2012;23:1193\u20139.","journal-title":"Int Urogynecol J"},{"key":"46_CR11","doi-asserted-by":"publisher","unstructured":"Giannantoni A. Patient-Reported Outcomes in Bladder Pain Syndrome: Qui Auget Dolorem, Auget et Scientiam (As Pain Increases, So Increases Knowledge). Eur Urol. 2012 Feb;61(2):280-1; discussion 282-3. doi: 10.1016\/j.eururo.2011.10.042 . Epub 2011 Nov 4.","DOI":"10.1016\/j.eururo.2011.10.042"},{"key":"46_CR12","doi-asserted-by":"crossref","unstructured":"D\u2019Amico AV, Whittington R, Malkowicz SB, Cote K, Loffredo M, Schultz D, et al. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era. Cancer. 2002;95:281\u20136.","DOI":"10.1002\/cncr.10657"},{"key":"46_CR13","unstructured":"RTOG http:\/\/www.rtog.org\/ResearchAssociates\/AdverseEventReporting.aspx . Accessed 11 January 2015"},{"key":"46_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1748-717X-3-15","volume":"3","author":"IM Lips","year":"2008","unstructured":"Lips IM, Dehnad H, van Gils CH, et al. High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker based position verification: acute and late toxicity in 331 patients. Radiat Oncol. 2008;3:15.","journal-title":"Radiat Oncol"},{"key":"46_CR15","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.ijrobp.2004.07.715","volume":"61","author":"ST Peeters","year":"2005","unstructured":"Peeters ST, Heemsbergen WD, van Putten WL, et al. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68\u00a0Gy to 78\u00a0Gy. Int J Radiat Oncol Biol Phys. 2005;61:1019\u201334.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"46_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","volume":"21","author":"B Emami","year":"1991","unstructured":"Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:109\u201322.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"46_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.radonc.2009.08.004","volume":"93","author":"C Fiorino","year":"2009","unstructured":"Fiorino C et al. Dose\u2013volume effects for normal tissues in external radiotherapy: Pelvis. Systematic review. Radiother Oncol. 2009;93:153\u201367.","journal-title":"Radiother Oncol"},{"key":"46_CR18","doi-asserted-by":"publisher","unstructured":"Costantini E, Lazzeri M, Porena M. GAGs and GAGs diseases: when pathophysiology supports the clinic. Urologia. 2013 Jul-Sep;80(3):173-8. doi: 10.5301\/RU.2013.11500 . Epub 2013 Sep 30.","DOI":"10.5301\/RU.2013.11500"},{"key":"46_CR19","first-page":"33","volume":"1","author":"Pier Francesco Bassi, Mauro Cervigni,Enrico Finazzi Agr\u00f2, Rocco Damiano, Roman Toma\u0161kin","year":"2013","unstructured":"Pier Francesco Bassi, Mauro Cervigni,Enrico Finazzi Agr\u00f2, Rocco Damiano, Roman Toma\u0161kin. Increasing evidence of effectiveness of GAG therapy in different forms of cystitis. Eur Med J \u2013 Urol. 2013;1:33\u201340.","journal-title":"Eur Med J \u2013 Urol"},{"key":"46_CR20","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.rpor.2013.05.006","volume":"18","author":"R Fuentes-Raspall","year":"2013","unstructured":"Fuentes-Raspall R, Inoriza JM, Rosello-Serrano A, Au\u00f1\u00f3n-Sanz C, Garcia-Martin P, Oliu-Isern G. Late rectal and bladder toxicity following radiation therapy for prostate cancer: predictive factors and treatment results. Rep Pract Oncol Radiother. 2013;18:298\u2013303.","journal-title":"Rep Pract Oncol Radiother"},{"key":"46_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/00365590410018738","volume":"39","author":"J R\u00f6ssberger","year":"2005","unstructured":"R\u00f6ssberger J, Fall M, Peeker R. Critical appraisal of dimethyl sulfoxide treatment for interstitial cystitis: discomfort, side-effects and treatment outcome. Scand J Urol Nephrol. 2005;39:73\u20137.","journal-title":"Scand J Urol Nephrol"},{"key":"46_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/nau.22256","volume":"32","author":"H Madersbacher","year":"2013","unstructured":"Madersbacher H, Van Ophoven A, Van Kerrebroeck PE. GAG layer replenishment therapy for chronic forms of cystitis with intravesical glycosaminoglycans \u2014 a review. Neurourol Urodyn. 2013;32:9\u201318.","journal-title":"Neurourol Urodyn"},{"key":"46_CR23","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/S0360-3016(99)00232-1","volume":"45","author":"MJ Zelefsky","year":"1999","unstructured":"Zelefsky MJ, Ginor RX, Fuks Z, et al. Efficacy of selective alpha-1 blocker therapy in the treatment of acute urinary symptoms during radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 1999;45:567\u201370.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12894-015-0046-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-015-0046-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-015-0046-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-015-0046-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T01:01:06Z","timestamp":1566954066000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-015-0046-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,7]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["46"],"URL":"https:\/\/doi.org\/10.1186\/s12894-015-0046-1","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,7]]},"assertion":[{"value":"14 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"65"}}